Valvular & structural heart disease

Diastolic delta best predicts paravalvular regurgitation after transcatheter aortic valve replacement as assessed by cardiac magnetic resonance: the APPOSE trial

Eur Heart J Cardiovasc ImagingPublished Diagnostic accuracy study

Authors' conclusion

DD measured during TAVR best predicts relevant PVR. Correction for heart rate (HR-DD) or systolic blood pressure (ARI, ARI ratio) did not improve this predictive value.

Study context

Population
Patients undergoing transcatheter aortic valve replacement (TAVR)
Participants
77 patients
Comparison
Haemodynamic indices of paravalvular regurgitation (PVR) measured during TAVR vs cardiac magnetic resonance (CMR)-derived regurgitant fraction
Outcome
Prediction of relevant PVR (CMR-RF > 20%) by AUC
Follow-up
1 month
Methodological detailsprospective, single-centre
  • Prospective
  • Single-centre

Performance

As reported in the abstract

Relevant PVR (CMR-RF > 20%)
Test or modelAUCOptimal cut-offSensitivitySpecificity
Diastolic delta (DD)0.82 (95% CI, 0.72-0.92)32 mmHg69%77%
HR-DD0.78 (95% CI, 0.67-0.89)
Aortic regurgitation index (ARI)0.78 (95% CI, 0.66-0.89)
ARI ratio0.65 (95% CI, 0.49-0.81)

AUC

Diastolic delta (DD)0.82 (95% CI, 0.72-0.92)
HR-DD0.78 (95% CI, 0.67-0.89)
Aortic regurgitation index (ARI)0.78 (95% CI, 0.66-0.89)
ARI ratio0.65 (95% CI, 0.49-0.81)

Optimal cut-off

Diastolic delta (DD)32 mmHg
HR-DD— not stated in the abstract
Aortic regurgitation index (ARI)— not stated in the abstract
ARI ratio— not stated in the abstract

Sensitivity

Diastolic delta (DD)69%
HR-DD— not stated in the abstract
Aortic regurgitation index (ARI)— not stated in the abstract
ARI ratio— not stated in the abstract

Specificity

Diastolic delta (DD)77%
HR-DD— not stated in the abstract
Aortic regurgitation index (ARI)— not stated in the abstract
ARI ratio— not stated in the abstract

Further findings

CMR-RF · 41 ± 14 days after TAVR

Mean CMR-RF
12.4 ± 9.3%
Patients with CMR-RF > 20%
15 (19.5%)

Original publication

Diastolic delta best predicts paravalvular regurgitation after transcatheter aortic valve replacement as assessed by cardiac magnetic resonance: the APPOSE trial. Eur Heart J Cardiovasc Imaging. Published 14 March 2023. doi:10.1093/ehjci/jead033

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.